the company is well-positioned right now, since getting their product approvals (fda and medicare reimbursement) and is now getting financing in place for marketing. i believe that conversions are on hold for a while, and new financing will delay additional conversions for a period of time. as a result, the pps should catapult to much higher levels well into pennyland. i think .25-.50 is very likely here, sooner than later. the company should also be putting out their quarterly financials in the upcoming two weeks, so we should see past debt paid down or completelypaid off and may see new notes in place that are restricted for six months. looking forward to a very huge move in igmb.
News 
Market Data 
Discover 
AI
